Natural Biocon (india) Share Price
Sector: Chemical Manufacturing
11.13 -0.13 (-1.15%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
10.83
Today’s High
11.30
52 Week Low
9.42
52 Week High
18.30
Key Metrics
- Market Cap (In Cr) 28.69
- Beta 1.29
- Div. Yield (%) 0
- P/B 1.02
- TTM P/E 197.54
- Sector P/E 0
- Open Price 11.27
- Prev Close 11.26
Natural Biocon (india) Analysis
Price Analysis
-
1 Week5.7%
-
3 Months-15.87%
-
6 Month-7.1%
-
YTD-16.38%
-
1 Year-15.87%
Risk Meter
- 57% Low risk
- 57% Moderate risk
- 57% Balanced Risk
- 57% High risk
- 57% Extreme risk
Natural Biocon (india) Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 13.53
- Selling/ General/ Admin Expenses Total
- 0.3
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.34
- Total Operating Expense
- 13.31
- Operating Income
- 0.23
- Net Income Before Taxes
- 0.23
- Net Income
- 0.15
- Diluted Normalized EPS
- 0.13
- Period
- 2024
- Total Assets
- 16.77
- Total Liabilities
- 4.38
- Total Equity
- 12.38
- Tangible Book Valueper Share Common Eq
- 10.89
- Period
- 2024
- Cashfrom Operating Activities
- -0.12
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.09
- Net Changein Cash
- -0.21
- Period
- 2023
- Total Revenue
- 1.25
- Selling/ General/ Admin Expenses Total
- 0.05
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.08
- Total Operating Expense
- 1.01
- Operating Income
- 0.25
- Net Income Before Taxes
- 0.25
- Net Income
- 0.18
- Diluted Normalized EPS
- 0.16
- Period
- 2023
- Total Assets
- 13.52
- Total Liabilities
- 1.29
- Total Equity
- 12.23
- Tangible Book Valueper Share Common Eq
- 10.75
- Period
- 2023
- Cashfrom Operating Activities
- 0.21
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.02
- Net Changein Cash
- 0.19
- Period
- 2022
- Total Revenue
- 0.48
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.08
- Total Operating Expense
- 0.39
- Operating Income
- 0.09
- Net Income Before Taxes
- 0.09
- Net Income
- 0.07
- Diluted Normalized EPS
- 0.06
- Period
- 2022
- Total Assets
- 12.3
- Total Liabilities
- 0.25
- Total Equity
- 12.05
- Tangible Book Valueper Share Common Eq
- 10.6
- Period
- 2022
- Cashfrom Operating Activities
- 0.19
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.15
- Net Changein Cash
- 0.04
- Period
- 2021
- Total Revenue
- 0.13
- Selling/ General/ Admin Expenses Total
- 0.01
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 0.13
- Operating Income
- 0
- Net Income Before Taxes
- 0
- Net Income
- 0
- Diluted Normalized EPS
- 0
- Period
- 2021
- Total Assets
- 12.38
- Total Liabilities
- 0.39
- Total Equity
- 11.99
- Tangible Book Valueper Share Common Eq
- 10.54
- Period
- 2021
- Cashfrom Operating Activities
- 0.32
- Cashfrom Financing Activities
- -0.32
- Net Changein Cash
- 0
- Period
- 2020
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 0.03
- Operating Income
- -0.03
- Net Income Before Taxes
- -0.03
- Net Income
- -0.03
- Diluted Normalized EPS
- -0.03
- Period
- 2020
- Total Assets
- 12.71
- Total Liabilities
- 0.73
- Total Equity
- 11.98
- Tangible Book Valueper Share Common Eq
- 10.54
- Period
- 2020
- Cashfrom Operating Activities
- 0.15
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.14
- Net Changein Cash
- 0.01
- Period
- 2019
- Total Revenue
- 0.45
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.31
- Total Operating Expense
- 0.34
- Operating Income
- 0.11
- Net Income Before Taxes
- 0.12
- Net Income
- 0.07
- Diluted Normalized EPS
- 0.06
- Period
- 2019
- Total Assets
- 13.02
- Total Liabilities
- 1
- Total Equity
- 12.01
- Tangible Book Valueper Share Common Eq
- 10.56
- Period
- 2019
- Cashfrom Operating Activities
- -0.86
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0.75
- Net Changein Cash
- -0.11
- Period
- 2024-12-31
- Total Revenue
- 1.28
- Selling/ General/ Admin Expenses Total
- 0
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.16
- Total Operating Expense
- 1.03
- Operating Income
- 0.25
- Net Income Before Taxes
- 0.25
- Net Income
- 0.25
- Diluted Normalized EPS
- 0.1
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 4.74
- Selling/ General/ Admin Expenses Total
- 0.07
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 4.53
- Operating Income
- 0.2
- Net Income Before Taxes
- 0.2
- Net Income
- 0.2
- Diluted Normalized EPS
- 0.08
- Period
- 2024-09-30
- Total Assets
- 36.26
- Total Liabilities
- 4.13
- Total Equity
- 32.14
- Tangible Book Valueper Share Common Eq
- 12.46
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0.63
- Cashfrom Investing Activities
- -19.53
- Cashfrom Financing Activities
- 19.28
- Net Changein Cash
- 0.38
- Period
- 2024-06-30
- Total Revenue
- 0.99
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 0.89
- Operating Income
- 0.1
- Net Income Before Taxes
- 0.1
- Net Income
- 0.1
- Diluted Normalized EPS
- 0.01
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 7.86
- Selling/ General/ Admin Expenses Total
- 0.26
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.25
- Total Operating Expense
- 7.92
- Operating Income
- -0.06
- Net Income Before Taxes
- -0.06
- Net Income
- -0.13
- Diluted Normalized EPS
- -0.12
- Period
- 2024-03-31
- Total Assets
- 16.77
- Total Liabilities
- 4.38
- Total Equity
- 12.38
- Tangible Book Valueper Share Common Eq
- 10.89
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -0.12
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.09
- Net Changein Cash
- -0.21
- Period
- 2023-12-31
- Total Revenue
- 5.4
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 5.17
- Operating Income
- 0.23
- Net Income Before Taxes
- 0.23
- Net Income
- 0.23
- Diluted Normalized EPS
- 0.09
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Natural Biocon (india) Technical
Moving Average
SMA
- 5 Day10.78
- 10 Day10.65
- 20 Day10.71
- 50 Day12.58
- 100 Day12.96
- 300 Day12.87
Natural Biocon (india) Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sawaca Enterprises
- 0.52
- -0.01
- -1.89
- 1.81
- 0.46
- 29.75
- Venlon Enterprises
- 5.52
- 0.15
- 2.79
- 9.74
- 4.48
- 28.83
- Natural Biocon (india)
- 11.13
- -0.13
- -1.15
- 18.3
- 9.42
- 28.69
- Raw Edge Industrial Solutions
- 26.01
- -0.55
- -2.07
- 46.8
- 23.62
- 26.13
- Jayshree Chemicals
- 8.35
- -0.17
- -2
- 12
- 6.8
- 24.43
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sawaca Enterprises
- 12.82
- 0.45
- 2.92
- 11.78
- Venlon Enterprises
- -
- -
- -
- -226.61
- Natural Biocon (india)
- 82.92
- 1.02
- 0.61
- 2.39
- Raw Edge Industrial Solutions
- -
- 1.2
- -0.59
- -0.28
- Jayshree Chemicals
- -
- 2.41
- -6.52
- -9.9
Natural Biocon (india) Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 23-May-25
- Audited Results
- 14-Feb-25
- Quarterly Results
- 09-Nov-24
- Quarterly Results
- 30-Oct-24
- Preferential issue of shares
- 24-Oct-24
- Others
- 14-Aug-24
- Quarterly Results
- 18-Jul-24
- Preferential issue of shares
- 30-May-24
- Audited Results
- 27-May-24
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 29-Nov-24
- 05-Nov-24
- EGM
- 30-Sept-24
- 16-Sept-24
- AGM
- 22-Sept-23
- 31-Aug-23
- AGM



